Showing 981 - 1,000 results of 108,614 for search '(( 5 ((((nn decrease) OR (we decrease))) OR (a decrease)) ) OR ( a point decrease ))', query time: 0.82s Refine Results
  1. 981

    Image_1_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neurons.... by Yize Li (471459)

    Published 2022
    “…We demonstrated artesunate prevented PINP in a dose-dependent manner, while exerting a clear anti-hyperalgesic effect on already existing PINP. …”
  2. 982
  3. 983

    Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”
  4. 984
  5. 985

    Phosphoproteomics Profiling Reveals Key Proteins Involved in Neuroinflammation and Impaired Axon Guidance Induced by Bilirubin Deficiency by Ming Chen (115604)

    Published 2025
    “…Golgi staining further revealed reduced number of dendritic intersections, branch points, shortened neurite length, and decreased dendritic complexity in <i>Blvra</i><sup><i>–/–</i></sup> mice compared to WT mice. …”
  6. 986
  7. 987
  8. 988
  9. 989
  10. 990

    A decrease in circulating CXCR5+CD4+ Tfh cells is associated with HCC progression, and CXCR5+CD4+ Tfh cells are decreased in tumor regions. by Yiqiong Jia (692871)

    Published 2015
    “…<p>(A) The prevalence of CXCR5+CD4+ Tfh cells decreases with progressive stages in HCC. …”
  11. 991
  12. 992
  13. 993
  14. 994

    Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies by Wenjing Dong (117921)

    Published 2016
    “…<i>5</i> (rs2227981) polymorphism is associated a strongly decreased risk of cancers. …”
  15. 995
  16. 996

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…At baseline, patients displayed overhydration (OH) with + 0.4 (-0.2 – 2.2) L/1.73m² which decreased by 0.5 (0.1 – 1.2) L/1.73m² after 6 months. …”
  17. 997

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…At baseline, patients displayed overhydration (OH) with + 0.4 (-0.2 – 2.2) L/1.73m² which decreased by 0.5 (0.1 – 1.2) L/1.73m² after 6 months. …”
  18. 998
  19. 999
  20. 1000